Immunomodulatory and pharmacologic properties of imiquimod
Top Cited Papers
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (1) , S6-S11
- https://doi.org/10.1067/mjd.2000.107808
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' CellsClinical Immunology, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848Cellular Immunology, 1999
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463Journal of Investigative Dermatology, 1998
- Cytokine induction by the immunomodulators imiquimod and S-27609Journal of Leukocyte Biology, 1995
- Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609Journal of Interferon & Cytokine Research, 1995
- Stimulation of Interferon and Cytokine Gene Expression by Imiquimod and Stimulation by Sendai Virus Utilize Similar Signal Transduction PathwaysMolecular and Cellular Biology, 1995
- Induction of Interferon and Other Cytokines by Imiquimod and Its Hydroxylated Metabolite R-842 in Human Blood Cells In VitroJournal of Interferon Research, 1994
- Cytokine induction in mice by the immunomodulator imiquimodJournal of Leukocyte Biology, 1994